FDA Drug Application (208026) for JENTADUETO XR by BOEHRINGER INGELHEIM

Back to FDA Applications sponsored by BOEHRINGER INGELHEIM

Application Number208026
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage2.5MG;1GM
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameJENTADUETO XR
Active IngredientLINAGLIPTIN; METFORMIN HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient LINAGLIPTIN4
List of drugs with Active Ingredient METFORMIN HYDROCHLORIDE32


Back to FDA Applications sponsored by BOEHRINGER INGELHEIM